Ericka Nelly Pompa-Mera

Dr. Ericka Nelly Pompa-Mera


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MRMoisés Hasim Rojas Rechy
Moisés Hasim Rojas Rechy
FGFélix Gaytán-Morales
Félix Gaytán-Morales
YSYessica Sánchez
Yessica Sánchez
ICIván Castorena-Villa
Iván Castorena-Villa
BMBRICEIDA LOPEZ MARTINEZ
BRICEIDA LOPEZ MARTINEZ
AMAbigail Morales-Sánchez
Abigail Morales-Sánchez
Infections remain a major cause of morbidity and mortality among hematopoietic stem cell transplant (HSCT) recipients. Unlike Epstein–Barr Virus (EBV) and Human Cytomegalovirus (HCMV), Human Herpesvirus (HHV) 6, HHV7 and HHV8 are not routinely monitored in many centers, especially in the pediatric population of low–medium income countries. We screened EBV, HCMV, HHV6, HHV7 and HHV8 in 412 leukocytes-plasma paired samples from 40 pediatric patients assisted in a tertiary hospital in Mexico. Thirty-two underwent allo-HSCT, whereas eight received auto-HSCT. Overall viral detection frequencies in allo- and auto-HSCT were: EBV = 43.7% and 30.0%, HCMV = 5.0% and 6.7%, HHV6 = 7.9% and 20.0% and HHV7 = 9.7% and 23.3%. HHV8 was not detected in any sample. Interestingly, HHV6 and HHV7 were more frequent in auto-HSCT, and HHV6 was observed in all episodes of multiple detection in auto-HSCT patients. We found EBV DNA in plasma samples, whereas HCMV, HHV6 and HHV7 DNA were predominantly observed in leukocytes, indicative of their expansion in cellular compartments. We also found that IL-1β, IL-2, IL-6 and IL-8 were significantly increased in episodes in which multiple viruses were simultaneously detected, and samples positive for EBV DNA and graft-versus-host disease had a further increase of IL-1β and IL-8. In conclusion, the EBV, HCMV, HHV6 and HHV7 burdens were frequently detected in allo- and auto-HSCT, and their presence associated with systemic inflammation.

25 October 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAna Miriam Ascencio Anastacio
Ana Miriam Ascencio Anastacio
VLVioleta Larios-Serrato
Violeta Larios-Serrato
JMJOSE Antonio MATA MARIN
JOSE Antonio MATA MARIN
MEMara Rodríguez Evaristo
Mara Rodríguez Evaristo
MNMireya Núñez-Armendáriz
Mireya Núñez-Armendáriz
Ericka Nelly Pompa-MeraEricka Nelly Pompa-Mera
Ericka Nelly Pompa-Mera
Background/Objectives: Excessive weight gain is a growing concern among people living with HIV (PWH) receiving integrase strand transfer inhibitor (INSTI)-based regimens as first-line antiretroviral therapy (ART), as it may contribute to multimorbidity. The mechanisms driving weight gain in INSTI users are not fully understood but are thought to be multifactorial. This study examines the plasma metabolome associated with weight gain in PWH on INSTI-based regimens. Methods: We conducted a nested case–control study within the randomized clinical trial MICTLAN (NCT06629480). Sixty-six participants were randomized to receive INSTI-based regimens, either bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC) or dolutegravir/abacavir/lamivudine (DTG/ABC/3TC), and followed for 18 months. Weight gain >10% relative to baseline was considered a primary endpoint and used as a criterium to categorize cases (n = 28) and controls (n = 38). Anthropometric and clinical measurements, plasma insulin, and metabolomic profiles were assessed at baseline and 18 months post-ART. Plasma untargeted metabolomics was performed using liquid chromatography–mass spectrometry (LC-MS/MS) to identify metabolomic changes linked to weight gain. Bioinformatic tools, including Partial Least Squares Discriminant Analysis (PLS-DA), volcano plots, and KEGG pathway enrichment analysis, were used to analyze plasma metabolomes and identify significant differential metabolites. Results: Weight gain at 18 months in PWH on INSTI-based ART was associated with insulin resistance, as measured by HOMA-IR (OR 3.23; 95% CI 1.14–9.10; p = 0.023), and visceral adipose tissue thickness > 4 cm (OR 4.50; 95% CI 1.60–13.03; 9.10; p = 0.004), and hypertriglyceridemia (OR 3.9; 95% CI 1.38–10.94; p = 0.008). Baseline HIV RNA viral load >50,000 copies/mL (OR 8.05; 95% CI 2.65–24.43; p = 0.0002) was identified as a baseline predictor of weight gain (aOR 6.58 (1.83–23.58); p = 0.004). In addition, accumulation of circulating medium-chain acylcarnitines, indicative of mitochondrial dysfunction, and insulin resistance were linked to weight gain in PWH on INSTI-based regimens after 18 months of therapy. Conclusions: This metabolomic study identified metabolites reflecting mitochondrial dysfunction, dysregulated lipid metabolism, and altered amino acid metabolism as key mechanisms underlying insulin resistance and weight gain in PWH on INSTI-based ART.

22 October 2021 in Pharmacogenetics and Genomics
Verified
Journal Article
Closed access
JBJonathan Saúl Bautista-Martínez
Jonathan Saúl Bautista-Martínez
JMJosé Antonio Mata-Marín
José Antonio Mata-Marín
JSJorge Luis Sandoval-Ramírez
Jorge Luis Sandoval-Ramírez
ACAlberto Chaparro-Sánchez
Alberto Chaparro-Sánchez
BMBulmaro Manjarrez-Téllez
Bulmaro Manjarrez-Téllez
Ericka Nelly Pompa-MeraEricka Nelly Pompa-Mera
Ericka Nelly Pompa-Mera
Objective: To investigate the impact of single nucleotide polymorphisms (SNPs) from APOA5, APOC3, CETP, ATP binding cassette transporter A1 and SIK3 genes in the development of hypertriglyceridemia in HIV patients under antiretroviral therapy. Material and Methods: A case-control study was developed. Leukocytic genomic DNA was extracted and genotyping for SNPs rs662799, rs964184, rs5128, rs2854116, rs2854117, rs3764261, rs4149310, rs4149267 and rs139961185 was performed by real time-PCR using TaqMan allelic discrimination assays, in Mexican mestizo patients with HIV infection, with hypertriglyceridemia (>1.7 mmol/L) under antiretroviral therapy. Genetic variants were also investigated in a control group of normolipidemic HIV patients (≤ 1.7 mmol/L). Haplotypes and gene interactions were analyzed. Results: A total of 602 HIV patients were genotyped (316 cases and 286 controls). Age and antiretroviral regimen based on protease inhibitors were associated with hypertriglyceridemia (P = 0.0001 and P = 0.0002. respectively). SNP rs964184 GG genotype in APOA5 gene exhibited the highest association with hypertriglyceridemia risk (OR, 3.2, 95% CI, 1.7–5.8, P = 0.0001); followed by SNP rs139961185 in SIK3 gene (OR = 2.3; (95% CI, 1.1–4.8; P = 0.03 for AA vs. AG genotype; and APOC3 rs5128 GG genotype, (OR, 2.2; 95% CI, 1.1–4.9; P = 0.04) under codominant models. These associations were maintained in the adjusted analysis by age and protease inhibitors based antiretroviral regimens. Conclusions: This study reveals an association between rs964184 in APOA5; rs5128 in APOC3 and rs139961185 in SIK3 and high triglyceride concentrations in Mexican HIV-patients receiving protease inhibitors. These genetic factors may influence the adverse effects related to antiretroviral therapy.

Verified
Journal Article
Open access
PDF file
JMJOSE Antonio MATA MARIN
JOSE Antonio MATA MARIN
MAMarisol Apaez-Iglesias
Marisol Apaez-Iglesias
ADAna Luz Cano Díaz
Ana Luz Cano Díaz
JNJuan Pablo Sánchez Navarro
Juan Pablo Sánchez Navarro
DFDiana Edith Fernández-Madinaveitia
Diana Edith Fernández-Madinaveitia
JGJesus Enrique Gaytan-Martínez
Jesus Enrique Gaytan-Martínez
Background/Objectives: Patients with immune-mediated inflammatory diseases (IMIDs) treated with disease-modifying antirheumatic drugs (DMARDs) are at increased risk of latent tuberculosis infection (LTBI) reactivation, influenced by DMARD type. This study aimed to determine LTBI prevalence using interferon-gamma release assays (IGRAs) and identify associated risk factors in IMID patients in a middle-high TB burden setting in Mexico. Methods: A cross-sectional study was conducted from July 2024 to April 2025 at an IMID clinic. Patients aged ≥18 years, either receiving DMARDs or prior to initiating treatment, were included. LTBI was diagnosed using the QuantiFERON-TB Gold Plus assay. Bivariate analysis was performed using the chi-square test, and multivariate analysis was conducted. Results: LTBI prevalence was 34.2% (95% CI 29.1–39.7%) according to QFT-Plus and 35.6% (95% CI 29.7–42.0%) according to TSTs (n = 230). Prior TB exposure was the strongest risk factor (aOR 4.20, 95% CI 1.74–10.12, p = 0.001), while rheumatoid arthritis was associated with a lower LTBI likelihood (aOR 0.31, 95% CI 0.16–0.59, p < 0.001). Conclusions: A high prevalence of LTBI was observed in patients with IMIDs treated with DMARDs. Prior tuberculosis exposure was strongly associated with LTBI. These findings highlight the importance of LTBI screening in this population to prevent reactivation.

2 October 2019
Verified
Book Chapter
Open access
PDF file
Mónica Salas-RojasMónica Salas-Rojas
Mónica Salas-Rojas
GGGálvez-Romero Guillermo
Gálvez-Romero Guillermo
Ericka Nelly Pompa-MeraEricka Nelly Pompa-Mera
Ericka Nelly Pompa-Mera
Currently, emerging viruses such as arboviruses, flaviviruses, filovirus, and orthohepeviruses are important agents of emerging zoonoses in public health, because their cycles are maintained in the nature or wildlife, involving hematophagous arthropod vectors and a wide range of vertebrate hosts as the bats. Development of blocking-transmission vaccines against these emerging viruses in wildlife will allow disease control at the veterinary field, preventing emerging human viral infections.

8 February 2025 in Viruses
Verified
Journal Article
Open access
PDF file
LULuis Antonio Uribe-Noguez
Luis Antonio Uribe-Noguez
MTMaria Erandhi Prieto Torres
Maria Erandhi Prieto Torres
LULuis Octavio Uribe-Noguez
Luis Octavio Uribe-Noguez
JMJOSE Antonio MATA MARIN
JOSE Antonio MATA MARIN
CACarla Ileana Arroyo-Anduiza
Carla Ileana Arroyo-Anduiza
AOAlicia Ocaña-Mondragón
Alicia Ocaña-Mondragón
Occult HCV infection (OCI) is defined by the presence of HCV RNA in hepatocytes and/or peripheral blood mononuclear cells (PBMCs) without detectable HCV RNA or anti-HCV antibodies in plasma. OCI is underrecognized and may contribute to HCV transmission. This study estimated OCI prevalence and associated risk factors in adults from Mexico City. Methods: A retrospective cross-sectional study was conducted, analyzing 507 general population volunteers. Demographic data and potential risk factors were collected via questionnaire. Anti-HCV detection was performed using two techniques: immunochromatographic rapid test and chemiluminescent microparticle immunoassay (CMIA). Nested PCR was employed to detect HCV RNA in plasma and PBMCs. Positive samples were genotyped through sequencing and phylogenetic analysis of the Core/E1 region. Results: Of 507 participants, four were anti-HCV positive. HCV RNA was found in PBMCs of 27 individuals, while plasma samples tested negative, indicating a 5.3% OCI prevalence. OCI was significantly associated with blood donation (p = 0.015), drug use (p = 0.019), particularly cocaine (p = 0.001), and endoscopy (p = 0.043). Genotypes 1b, 1a, 2b, 3a, and 2j were detected in OCI cases. Conclusions: OCI prevalence in Mexico City’s general population is notable, with significant links to blood donation, cocaine use, and endoscopy. Enhanced diagnostic strategies are crucial to detect OCI and mitigate HCV transmission.